Showing 1,282 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Pharmaceutical industry

Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA

Editor's pick
Gilead press release
22 April 2014
PrEP

Px Wire: Long-Acting Injectables

Editor's pick
AVAC
17 April 2014
New & experimental HIV treatments

Bristol-Myers Squibb Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1

Editor's pick
Bristol-Myers Squibb press release
15 April 2014
The search for a cure

Transplant Drugs May Fight HIV Reservoir

Editor's pick
AIDSMeds
14 April 2014
New & experimental HIV treatments

Nano-sized drug particles to expand HIV treatment further

Editor's pick
Medical Xpress
9 April 2014
Injectable & long-acting HIV treatment

Long-acting HIV drugs advanced to overcome adherence challenge

Editor's pick
Nature Medicine
8 April 2014
Access to healthcare

Viiv Healthcare licenses dolutegravir (Tivicay) to Medicines Patent Pool

Editor's pick
Viiv Healthcare press release
2 April 2014
New & experimental HIV treatments

Janssen Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat as Part of Combination HIV Therapy

Editor's pick
Janssen press release
2 April 2014
HIV treatment

New NNRTI doravirine matches efavirenz for first-line HIV treatment

News
11 March 2014
Changing treatment

Viral load rebounds in 35% of people using PI/r monotherapy: results of five-year PIVOT study

Editor's pick
HIV i-Base
10 March 2014
New & experimental HIV treatments

Novel two-drug maintenance combination works at least as well as triple therapy: stage set for long-lasting injectable formulation

News
8 March 2014
New & experimental HIV treatments

Protected T-cells persist and proliferate in HIV gene therapy study

News
7 March 2014
The search for a cure

The 'Boston patients' experience HIV rebound after stem cell transplants

News
7 March 2014
New & experimental HIV treatments

HIV attachment inhibitor BMS-663068 shows good safety and efficacy in phase 2b study

News
6 March 2014
The search for a cure

HIV gene therapy using GM cells hailed a success after trial

Editor's pick
The Guardian
5 March 2014
Injectable & long-acting PrEP

Monkey studies confirm viability of injectable PrEP drug

News
5 March 2014
New & experimental HIV treatments

UK: Once-daily HIV pill Tivicay from ViiV gets launch

Editor's pick
Pharma Times
5 February 2014
New & experimental HIV treatments

Researchers open door to new HIV therapy

Editor's pick
University of California Berkeley press release
30 January 2014
Clinical trials

Quality Of Evidence Used By FDA To Approve New Drugs Varies Widely

Editor's pick
Forbes
22 January 2014
New & experimental HIV treatments

ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe

Editor's pick
ViiV Healthcare press release
21 January 2014
The search for a cure

NIH-created toxin can kill HIV-infected cells that persist despite treatment

Editor's pick
Eurekalert Medicine & Health
10 January 2014
HIV treatment for children & young people

Merck Receives FDA Approval for ISENTRESS(R) (raltegravir) for Pediatric Oral Suspension

Editor's pick
Wall Street Journal
9 January 2014
New & experimental HIV treatments

Vertex's VX-765 holds promise for HIV treatment

Editor's pick
Motley Fool
7 January 2014
Starting treatment

Short course of ART during primary HIV infection has immunological and virological benefits after treatment is stopped

News
27 December 2013